Home › Disorders of Excessive Somnolence › New Jersey
Disorders of Excessive Somnolence clinical trials in New Jersey
5 studies for Disorders of Excessive Somnolence are looking for participants at sites in New Jersey.
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Middletown
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 3, 2026 · NCT07455383A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Middletown
RecruitingPhase 2/3
Ages 18 to 70 · All sexes · Updated Aug 7, 2026 · NCT06767683Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Cherry Hill
- Clinical Research Site, Toms River
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jul 24, 2026 · NCT07484217Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
- Clinical Research Site, Middletown
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jul 24, 2026 · NCT06568367A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age
- Site #2, Eatontown
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 80 · All sexes · Updated Dec 24, 2025 · NCT07082829From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.